Charité

Our most important university partner for translational research activities is the Charité - Universitätsmedizin Berlin.

 

Since 2007, the two institutions have jointly run the experimental and clinical research center (ECRC), a center for translational medicine on the Campus Buch. The Max Delbrück Center and the Charité have extended their joint activities even further by forming the Berlin Institute of Health (BIH), which is focusing on translational systems medicine research.

Article

Altuna Akalin
Science

Altuna Akalin awarded professorship

Altuna Akalin has been appointed a professorship at Charité – Universitätsmedizin Berlin. The position will enable closer collaboration with clinicians and faster application of bioinformatics in clinical care.
Mass spektrometer
Science

Three drugs work better than two

A combination of three drugs appears to more effectively treat people with cystic fibrosis than therapy with only two, concludes a study by Max Delbrück Center researchers published in “Cell Systems.” The study analyzed changes in the proteomes of blood and sputum samples from people with the disease.
Scientific image
Science

Distinct metabolic signature found in HFpEF

Researchers at the the Deutsches Herzzentrum der Charité and the Max Delbrück Center have identified a unique metabolic fingerprint in the hearts of patients with HFpEF and obesity. The findings, which were published in “Cardiovascular Research,” point to new drug targets.
Detlev Ganten
Institute & Campus

Happy 85th birthday, Detlev Ganten!

The founding director of the Max Delbrück Center, physician and pharmacologist Detlev Ganten, celebrates his 85th birthday on March 28, 2026. Without his commitment, our research center would not exist as we know it today. Once again, we say thank you and offer our heartfelt congratulations!
Wissenschaftliches Bild
Press Release No. 5 Berlin

Launch of the Einstein Center for Early Disease Interception

At the Einstein Center for Early Disease Interception, researchers from twelve Berlin institutions will be pooling their expertise to explore new approaches to prevention, long before symptoms appear, and bring them quickly into practice. The center opens today with a ceremony.
Scientific image
Science

Fat tissue fuels gut inflammation

Researchers at the Max Delbrück Center and Charité – Universitätsmedizin Berlin show that adipose tissue amplifies gut inflammation in Crohn’s disease. The study, published in the “Journal of Clinical Investigation,” also reveals how genetic changes in immune cells may contribute to the disease.
Mina Gouti
Science

Professorship awarded to Mina Gouti

Mina Gouti has been awarded a professorship at Charité – Universitätsmedizin Berlin. The appointment will strengthen her pioneering organoid research at the Max Delbrück Center and deepen collaboration with clinicians to advance personalized medicine.
Ludwig Leif
Science

Leif Si-Hun Ludwig awarded professorship

Leif Si-Hun Ludwig has been awarded a prestigious Heisenberg professorship in stem cell dynamics and mitochondrial genomics by the the Berlin Institute of Health at Charité, a position funded by the German Research Foundation (DFG).
Scientific image
Science

A double-pronged attack on malignant B cells

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant cells to destroy the cancer more effectively.
Nikolaus Rajewsky und Leif Sander
Science

A new opportunity for Berlin

The Einstein Center for Early Disease Interception has been funded with six million euros. In an interview, Nikolaus Rajewsky and Leif Erik Sander, both spokespeople of the center, explain why new technologies and cross-institutional collaboration will make disease prevention in the future possible.